News

11/01/2018 - Xeris Pharmaceuticals Announces FDA Acceptance for Review of NDA for Its Ready-to-Use Glucagon Rescue Pen

Read more

09/26/2018 - Successful Launch of Mérieux Participations 3, The new growth Capital Fund of Mérieux Equity Partners

Read More

09/05/2018 - Inscripta Announces Strategic Acquisition of Solana Biosciences

Read more

08/13/2018 - Xeris Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Highlights

Read more

08/13/2018 - Ivantis announces FDA approval for its innovative Hydrus Microstent Device for Minimally Invasive Glaucoma Surgery (MIGS)

Read more

07/13/2018 - Biom’up obtains CE Mark for its HEMOBLASTTM Bellows Laparoscopic Applicator

Read more

07/12/2018 - Inscripta Granted Patents for CRISPR Gene-Editing Systems

Read more

06/28/2018 - Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offering in the U.S.

Read more

06/25/2018 - XERIS PHARMACEUTICALS announces positive phase 3 clinical trial data on its investigational ready-to-use Glucagon rescue pen

Read more

06/20/2018 - GIMV and Merieux Developpement accelerate the expansion of SGH Healthcaring

Read more